Yüklüyor......
Auranofin Suppresses Plasminogen Activator Inhibitor-2 Expression through Annexin A5 Induction in Human Prostate Cancer Cells
Auranofin has been developed as antirheumatic drugs, which is currently under clinical development for the treatment of chronic lymphocytic leukemia. Previous report showed that auranofin induced apoptosis by enhancement of annexin A5 expression in PC-3 cells. To understand the role of annexin A5 in...
Kaydedildi:
| Yayımlandı: | Biomol Ther (Seoul) |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Korean Society of Applied Pharmacology
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340543/ https://ncbi.nlm.nih.gov/pubmed/27956714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2016.223 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|